为您找到相关结果约88个

你是不是要搜索 期刊Lantus 点击跳转

Rezvoglar - Another Insulin Glargine Product Interchangeable with Lantus

LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics

Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus((R))): a randomized

Application of Gurma Melon (Citrullus lantus var. colocynthoides) Pulp-Based Gel Fat Replacer in Mayonnaise

Signal detection using longitudinal healthcare claims data; a pilot study using Lantus as case drug

Comparison of Toujeo and Lantus for treatment of diabetes in pregnancy

A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type

Comparison of Toujeo and Lantus for treatment of diabetes mellitus in pregnancy

Immunogenicity of LY2963016 insulin glargine and Lantus (R) insulin glargine in Chinese patients with

with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus

Efficacy and Safety between Insulin Glargine Products (LY2963016 and Lantus (R)) in Patients with T2DM

Real-World Impact of Switching From Insulin Glargine (Lantus (R)) to Basaglar (R) and Potential Cost

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine

Lilly Insulin Glargine Versus Lantus((R)) in Insulin-Naive and Insulin-Treated Adults with Type 2 Diabetes

Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus(A (R))) and Lantus

为您找到相关结果约88个

共88条页码: 1/6页15条/页